STOK - Stoke Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

STOK is currently covered by 9 analysts with an average price target of $26.15. This is a potential upside of $14.49 (124.27%) from yesterday's end of day stock price of $11.66.

Stoke Therapeutics's activity chart (see below) currently has 27 price targets and 54 ratings on display. The stock rating distribution of STOK is 93.94% BUY and 6.06% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.31% with an average time for these price targets to be met of 123.18 days.

Highest price target for STOK is $35, Lowest price target is $12, average price target is $26.15.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 11-Apr-2024. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of STOK, 31 are a BUY (93.94%), 2 are a HOLD (6.06%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

22

$10.75 (95.56%)

22

13 days ago

5/13 (38.46%)

$8.5 (62.96%)

48

Hold

13

$1.75 (15.56%)

27

29 days ago

3/5 (60%)

$2.71 (26.34%)

15

Buy

17

$5.75 (51.11%)

25

29 days ago

2/6 (33.33%)

$6.71 (65.21%)

48

Buy

35

$23.75 (211.11%)

35

29 days ago

0/4 (0%)

$24.71 (240.14%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STOK (Stoke Therapeutics) average time for price targets to be met?

On average it took 123.18 days on average for the stock forecasts to be realized with a an average price target met ratio 35.31

Which analyst has the current highest performing score on STOK (Stoke Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on STOK (Stoke Therapeutics)?

Alethia Young has 5 price targets and 5 ratings on STOK

Which analyst is the currently most bullish on STOK (Stoke Therapeutics)?

Michelle Gilson with highest potential upside - $65.75

Which analyst is the currently most reserved on STOK (Stoke Therapeutics)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?